These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9862830)

  • 21. Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1.
    Nagell CF; Wettergren A; Pedersen JF; Mortensen D; Holst JJ
    Scand J Gastroenterol; 2004 Apr; 39(4):353-8. PubMed ID: 15125467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
    Lavin JH; Wittert GA; Andrews J; Yeap B; Wishart JM; Morris HA; Morley JE; Horowitz M; Read NW
    Am J Clin Nutr; 1998 Sep; 68(3):591-8. PubMed ID: 9734735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide regulation of feeding in catfish, Ictalurus punctatus: a role for glucagon-like peptide-1 (GLP-1)?
    Silverstein JT; Bondareva VM; Leonard JB; Plisetskaya EM
    Comp Biochem Physiol B Biochem Mol Biol; 2001 Jun; 129(2-3):623-31. PubMed ID: 11399498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
    Verdich C; Flint A; Gutzwiller JP; Näslund E; Beglinger C; Hellström PM; Long SJ; Morgan LM; Holst JJ; Astrup A
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4382-9. PubMed ID: 11549680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small intestinal protein infusion in humans: evidence for a location-specific gradient in intestinal feedback on food intake and GI peptide release.
    van Avesaat M; Ripken D; Hendriks HF; Masclee AA; Troost FJ
    Int J Obes (Lond); 2017 Feb; 41(2):217-224. PubMed ID: 27811949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects.
    Kong MF; Chapman I; Goble E; Wishart J; Wittert G; Morris H; Horowitz M
    Peptides; 1999; 20(5):545-51. PubMed ID: 10465505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a preload on reduction of food intake by GLP-1 in healthy subjects.
    Degen L; Oesch S; Matzinger D; Drewe J; Knupp M; Zimmerli F; Beglinger C
    Digestion; 2006; 74(2):78-84. PubMed ID: 17135729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
    Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
    Eur J Pharmacol; 2002 Apr; 440(2-3):269-79. PubMed ID: 12007541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans.
    Schjoldager BT; Mortensen PE; Christiansen J; Orskov C; Holst JJ
    Dig Dis Sci; 1989 May; 34(5):703-8. PubMed ID: 2714145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraduodenal infusion of a combination of tastants decreases food intake in humans.
    van Avesaat M; Troost FJ; Ripken D; Peters J; Hendriks HF; Masclee AA
    Am J Clin Nutr; 2015 Oct; 102(4):729-35. PubMed ID: 26289437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
    Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
    Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.
    Hvidberg A; Nielsen MT; Hilsted J; Orskov C; Holst JJ
    Metabolism; 1994 Jan; 43(1):104-8. PubMed ID: 8289665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An interaction between hypothalamic glucagon-like peptide-1 and macronutrient composition determines food intake in rats.
    Choi YH; Anderson GH
    J Nutr; 2001 Jun; 131(6):1819-25. PubMed ID: 11385073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans.
    Flint A; Raben A; Rehfeld JF; Holst JJ; Astrup A
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):288-98. PubMed ID: 10757621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility.
    MacIntosh CG; Andrews JM; Jones KL; Wishart JM; Morris HA; Jansen JB; Morley JE; Horowitz M; Chapman IM
    Am J Clin Nutr; 1999 May; 69(5):999-1006. PubMed ID: 10232642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men.
    Steinert RE; Luscombe-Marsh ND; Little TJ; Standfield S; Otto B; Horowitz M; Feinle-Bisset C
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3275-84. PubMed ID: 24926954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.